Bioequivalence and Bioavailability
COMPARISON OF BIOAVAILABILITY AND BIOEQUIVALENCE OF HERBAL ANXIOLYTIC DRUGS WITH MARKETED DRUG ALPRAZOLAM
9
“Review on Bioavailability and Bioequivalence Studies” by Kambham Venkateswarlu, J. Thirumaran, India. Digital copy link
9
REASONS FOR PARTICIPATION AND PROBLEMS ENCOUNTERED BY HEALTHY VOLUNTEERS IN BIOAVAILABILITY / BIOEQUIVALENCE STUDIES
6
BIOEQUIVALENCE AND BIOAVAILABILITY STUDY OF ANTIHYPERTENSIVE DRUG: A REVIEW
10
New Drugs and Clinical Trials Rules, 2019: Towards Fast-track Accessibility of New Drugs to the Indian Population
9
ETHICAL GUIDELINES AND STUDY DESIGN FOR BIOAVAILABILITY AND BIOEQUIVALENCE STUDY
6
A SELECTIVE AND SENSITIVE LIQUID CHROMATOGRAPHIC/ TANDEM MASS SPECTROMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF OSELTAMIVIR AND ITS METABOLITE OSELTAMIVIR CARBOXYLIC ACID IN HUMAN PLASMA FOR BIOAVAILABILITY OR BIOEQUIVALENCE STUDIES
17
A REVIEW ON GENERAL CONCEPTS OF DESIGN AND CONDUCT OF BIOEQUIVALENCE STUDIES
11
Bioequivalence studies - A regulatory perspective
12
Simultaneous confidence regions for multivariate bioequivalence
20
Generic Drugs and Bioequivalence for its Approval
8
Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
5
Module 6 Product or profile comparison – product similarity or interchangeability.pdf
40
STUDY OF THE BIOEQUIVALENCE OF ANTI-BENIGN PROSTATIC HYPERPLASIA DRUG IN HEALTHY ADULT, MALE HUMAN SUBJECTS, UNDER FED CONDITION
9
Relative bioavailability of diazoxide, manufactured at two different international locations, in healthy participants under fasting conditions: an open-label, two-stage, adaptive, sequential two-period crossover study
9
“Bioavailability & Bioequivalence: The Past, Present and Costly Affairs of a Global Concept Used Locally” by Priyanka Harbola, India.
10
DEVELOPMENT AND IN VIVO EVALUATION OF NELFINAVIR EXTENDED RELEASE TRILAYER MATRIX TABLETS IN THE MANAGEMENT OF AIDS
9
DEVELOPMENT AND BIOEQUIVALENCE STUDY OF OLANZAPINE 10mg TABLETS
6
Enhancing Bioavailability Of Drugs
11
Investigation of Different Formulation Approaches to Enhance Oral Bioavailability of Paromomycin
8